Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
Author:
Affiliation:
1. Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine Kyoto Japan
2. Agilent Technologies, Chromatography Mass Spectrometry Sales Department Life Science and Applied Markets Group Tokyo Japan
Publisher
Wiley
Subject
Physiology (medical),Orthopedics and Sports Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12814
Reference42 articles.
1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
2. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
3. SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
4. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
5. The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system;Translational Neurodegeneration;2024-08-09
2. A multi‐omics approach to overeating and inactivity‐induced muscle atrophy in db/db mice;Journal of Cachexia, Sarcopenia and Muscle;2024-07-13
3. Empagliflozin rescues lifespan and liver senescence in naturally aged mice;GeroScience;2024-06-26
4. Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments;Cell Metabolism;2024-06
5. Association between grip strength and albuminuria in the general United States population: NHANES 2011–2014;Frontiers in Public Health;2024-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3